Glickman Mark A
Transaction: 06/08/2026
BUY
Change
+17,186
Price
Not reported
Filing
06/08/2026
Type
BUY
MetaVia Inc.
MTVA • Biotechnology
$1.77
— 0.00 (0.00%)
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$8.60M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.04Healthy liquidity · 1.93Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 14, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.77
Change0.00%
Shares Out4.86M
Market Cap$8.60M
Enterprise Value$-5.06M
52W Range0.97 - 19.03
Beta0.92
P/E-0.66
P/B0.95
P/FCF-0.57
EV/EBITDA0.37
EV/FCF0.33
Price$1.77
Change0.00%
Shares Out4.86M
Market Cap$8.60M
Enterprise Value$-5.06M
52W Range0.97 - 19.03
Beta0.92
P/E-0.66
P/B0.95
P/FCF-0.57
EV/EBITDA0.37
EV/FCF0.33
Earnings Yield-152.59%
FCF Yield-176.09%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.04
Current Ratio1.93
Quick Ratio1.93
Volume907.49K
Avg Volume3.67M
EPS Surprise-0.03
Investment DNA
How strong this company looks for long-term investors
45
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
80/100
Why this score▼
Manageable debt level · 0.04Healthy liquidity · 1.93Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 2 analyst votes · 2026-09-04
100/100
Bullish
Bullish
2
Hold
0
Bearish
0
Insider Transactions
Recent executive and insider activity
KOVEN ANDREW I
Transaction: 06/08/2026
BUY
Change
+17,186
Price
Not reported
Filing
06/08/2026
Type
BUY
GROVES JASON L
Transaction: 06/08/2026
BUY
Change
+17,186
Price
Not reported
Filing
06/08/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Glickman Mark A | BUY | +17,186 | Not reported | 06/08/2026 | 06/08/2026 |
| KOVEN ANDREW I | BUY | +17,186 | Not reported | 06/08/2026 | 06/08/2026 |
| GROVES JASON L | BUY | +17,186 | Not reported | 06/08/2026 | 06/08/2026 |
| Salsbury Michael | BUY | +17,186 | Not reported | 06/08/2026 | 06/08/2026 |
| STRICKLAND D GORDON | BUY | +17,186 | Not reported | 06/08/2026 | 06/08/2026 |
| Tursi James Patrick | BUY | +17,186 | Not reported | 06/08/2026 | 06/08/2026 |
| Kim Hyung Heon | BUY | +32,000 | Not reported | 01/23/2026 | 01/27/2026 |
| Woodworth Marshall H | BUY | +28,000 | Not reported | 01/23/2026 | 01/27/2026 |
| Woodworth Marshall H | SELL | -14,200 | Not reported | 08/12/2025 | 08/13/2025 |
| Salsbury Michael | BUY | +28,147 | Not reported | 06/30/2025 | 07/01/2025 |
| KOVEN ANDREW I | BUY | +28,147 | Not reported | 06/30/2025 | 07/01/2025 |
| STRICKLAND D GORDON | BUY | +28,147 | Not reported | 06/30/2025 | 07/01/2025 |
| Tursi James Patrick | BUY | +28,147 | Not reported | 06/30/2025 | 07/01/2025 |
| GROVES JASON L | BUY | +28,147 | Not reported | 06/30/2025 | 07/01/2025 |
| Glickman Mark A | BUY | +28,147 | Not reported | 06/30/2025 | 07/01/2025 |
| Woodworth Marshall H | BUY | +14,200 | $0.70 | 06/04/2025 | 06/04/2025 |
| DONG-A ST CO., LTD | BUY | +4,647,887 | $0.71 | 05/08/2025 | 05/20/2025 |
| Kim Hyung Heon | SELL | -2,795 | $1.46 | 03/01/2025 | 03/04/2025 |
| Woodworth Marshall H | SELL | -3,417 | $1.46 | 03/01/2025 | 03/04/2025 |
| Kim Hyung Heon | SELL | -2,867 | $2.55 | 11/30/2024 | 12/02/2024 |